192 related articles for article (PubMed ID: 31771368)
1. Tenosynovial Giant Cell Tumor, Localized Type With Extensive Chondroid Metaplasia: A Case Report With Immunohistochemical and Molecular Genetic Analysis.
Nagase M; Araki A; Ishikawa N; Nagano N; Fujimoto M; Biyajima K; Yamagami N; Yamamoto S; Maruyama R
Int J Surg Pathol; 2020 Jun; 28(4):447-453. PubMed ID: 31771368
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic utility of CSF1 immunohistochemistry in tenosynovial giant cell tumor for differentiating from giant cell-rich tumors and tumor-like lesions of bone and soft tissue.
Sugita S; Takenami T; Kido T; Aoyama T; Hosaka M; Segawa K; Sugawara T; Fujita H; Shimizu J; Murahashi Y; Emori M; Hasegawa T
Diagn Pathol; 2022 Nov; 17(1):88. PubMed ID: 36320082
[TBL] [Abstract][Full Text] [Related]
3. Intramuscular Tenosynovial Giant Cell Tumor Harboring a Novel
Mejbel H; Siegal GP; Wei S
Int J Surg Pathol; 2022 May; 30(3):335-338. PubMed ID: 34657489
[TBL] [Abstract][Full Text] [Related]
4. Optimal Treatment for Tenosynovial Giant Cell Tumor of the Hand.
Kitagawa Y; Takai S
J Nippon Med Sch; 2020 Sep; 87(4):184-190. PubMed ID: 32350187
[TBL] [Abstract][Full Text] [Related]
5. Massively parallel sequencing of tenosynovial giant cell tumors reveals novel CSF1 fusion transcripts and novel somatic CBL mutations.
Tsuda Y; Hirata M; Katayama K; Motoi T; Matsubara D; Oda Y; Fujita M; Kobayashi H; Kawano H; Nishida Y; Sakai T; Okuma T; Goto T; Ogura K; Kawai A; Ae K; Anazawa U; Suehara Y; Iwata S; Miyano S; Imoto S; Shibata T; Nakagawa H; Yamaguchi R; Tanaka S; Matsuda K
Int J Cancer; 2019 Dec; 145(12):3276-3284. PubMed ID: 31107544
[TBL] [Abstract][Full Text] [Related]
6. Malignant Tenosynovial Giant Cell Tumor: The True "Synovial Sarcoma?" A Clinicopathologic, Immunohistochemical, and Molecular Cytogenetic Study of 10 Cases, Supporting Origin from Synoviocytes.
Al-Ibraheemi A; Ahrens WA; Fritchie K; Dong J; Oliveira AM; Balzer B; Folpe AL
Mod Pathol; 2019 Feb; 32(2):242-251. PubMed ID: 30206409
[TBL] [Abstract][Full Text] [Related]
7. Chondroid tenosynovial giant cell tumor: a clinicopathological and immunohistochemical analysis of 5 new cases.
Hoch BL; Garcia RA; Smalberger GJ
Int J Surg Pathol; 2011 Apr; 19(2):180-7. PubMed ID: 21087985
[TBL] [Abstract][Full Text] [Related]
8. A novel colony-stimulating factor 1 (CSF1) translocation involving human endogenous retroviral element in a tenosynovial giant cell tumor.
Lipplaa A; Meijer D; van de Sande MAJ; Gelderblom H; Bovée JVMG; Mei H; Szuhai K
Genes Chromosomes Cancer; 2023 Apr; 62(4):223-230. PubMed ID: 36504457
[TBL] [Abstract][Full Text] [Related]
9. RNAscope CSF1 chromogenic in situ hybridization: a potentially useful tool in the differential diagnosis of tenosynovial giant cell tumors.
Thangaiah JJ; Koepplin JW; Folpe AL
Hum Pathol; 2021 Sep; 115():1-9. PubMed ID: 34058245
[TBL] [Abstract][Full Text] [Related]
10. Fine Needle Aspiration Cytology of Diffuse-Type Tenosynovial Giant Cell Tumors.
Zhao Z; Paquette C; Shah AA; Atkins KA; Frierson HF
Acta Cytol; 2017; 61(2):160-164. PubMed ID: 28324880
[TBL] [Abstract][Full Text] [Related]
11. Detection of CSF1 rearrangements deleting the 3' UTR in tenosynovial giant cell tumors.
Ho J; Peters T; Dickson BC; Swanson D; Fernandez A; Frova-Seguin A; Valentin MA; Schramm U; Sultan M; Nielsen TO; Demicco EG
Genes Chromosomes Cancer; 2020 Feb; 59(2):96-105. PubMed ID: 31469468
[TBL] [Abstract][Full Text] [Related]
12. Clinical and morphological correlations and histopathology of joint damage in patients with diffuse-type tenosynovial giant cell tumor.
Dyadyk OO; Hryhorovska AV
Wiad Lek; 2019; 72(12 cz 1):2269-2276. PubMed ID: 32124739
[TBL] [Abstract][Full Text] [Related]
13. Does CSF1 overexpression or rearrangement influence biological behaviour in tenosynovial giant cell tumours of the knee?
Mastboom MJL; Hoek DM; Bovée JVMG; van de Sande MAJ; Szuhai K
Histopathology; 2019 Jan; 74(2):332-340. PubMed ID: 30152874
[TBL] [Abstract][Full Text] [Related]
14. Chondroid Tenosynovial Giant Cell Tumor of the Temporomandibular Joint: A Rare Case Report.
Anbinder AL; Geraldo BMC; Guimarães R; Pereira DL; Almeida OP; Carvalho YR
Braz Dent J; 2017; 28(5):647-652. PubMed ID: 29215692
[TBL] [Abstract][Full Text] [Related]
15. Giant Cell Poor Extra-Articular Diffuse-Type Tenosynovial Giant Cell Tumor With Extensive Desmin Expression: A Potential Diagnostic Pitfall With Cytogenetic Confirmation.
Lopez L; Schoedel K; John I
Int J Surg Pathol; 2019 Feb; 27(1):59-61. PubMed ID: 30019981
[TBL] [Abstract][Full Text] [Related]
16. Tenosynovial Giant Cell Tumor of the Retropharynx: A Case Report With Literature Review.
Liu G; Liu F
Ear Nose Throat J; 2021 Feb; 100(2):112-115. PubMed ID: 33048582
[TBL] [Abstract][Full Text] [Related]
17. A landscape effect in tenosynovial giant-cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells.
West RB; Rubin BP; Miller MA; Subramanian S; Kaygusuz G; Montgomery K; Zhu S; Marinelli RJ; De Luca A; Downs-Kelly E; Goldblum JR; Corless CL; Brown PO; Gilks CB; Nielsen TO; Huntsman D; van de Rijn M
Proc Natl Acad Sci U S A; 2006 Jan; 103(3):690-5. PubMed ID: 16407111
[TBL] [Abstract][Full Text] [Related]
18. Molecular identification of COL6A3-CSF1 fusion transcripts in tenosynovial giant cell tumors.
Möller E; Mandahl N; Mertens F; Panagopoulos I
Genes Chromosomes Cancer; 2008 Jan; 47(1):21-5. PubMed ID: 17918257
[TBL] [Abstract][Full Text] [Related]
19. [Tenosynovial giant cell tumor].
Kuhnen C; Müller KM; Rabstein S; Kasprzynski A; Herter P
Pathologe; 2005 Mar; 26(2):96-110. PubMed ID: 15657685
[TBL] [Abstract][Full Text] [Related]
20. Malignant tenosynovial giant cell tumor with CDKN2A/B genomic alteration: a histological, immunohistochemical, and molecular study.
Alexiev BA; Tumer Y; Yang GY
Hum Pathol; 2017 May; 63():144-148. PubMed ID: 27989786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
